Parallax Volatility Advisers
JUNO

Parallax Volatility Advisers’s Juno Therapeutics, Inc. JUNO Stock Holding History

Parallax Volatility Advisers’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-24,400
Closed -$1.09M – 5367
2017
Q3 		$1.09M Buy
+24,400
New +$832K ﹤0.01% 1041
2015
Q3 		– Sell
-39,600
Closed -$2.11M – 4801
2015
Q2 		$2.11M Buy
+39,600
New +$2.1M ﹤0.01% 1042

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Parallax Volatility Advisers's JUNO Position: Q4 2017 in Review

Parallax Volatility Advisers sold out of Juno Therapeutics, Inc. (JUNO) in Q4 2017, closing a stake of 1,246 shares — an estimated $62.2K sold.

Parallax Volatility Advisers first reported a position in JUNO in Q2 2015 and held it in 3 quarters. The position peaked at $651K in Q2 2015. 237 funds tracked by Wall St. Rank hold JUNO as of Q4 2017.

  • Parallax Volatility Advisers reported no remaining Juno Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
  • Parallax Volatility Advisers sold 1,246 Juno Therapeutics, Inc. shares in Q4 2017, an estimated $62.2K.
  • Parallax Volatility Advisers first reported a position in Juno Therapeutics, Inc. in Q2 2015 and held it in 3 quarters.
  • Parallax Volatility Advisers's Juno Therapeutics, Inc. position peaked at $651K in Q2 2015.
  • 237 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q4 2017.

Based on Parallax Volatility Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.